Additional Medications for Neuropathic Facial Pain Poorly Controlled with Lyrica 150mg TID
Before adding another medication, first optimize your pregabalin dose to 200mg TID (600mg/day total), as the patient is currently on 450mg/day which is below the maximum FDA-approved dose for neuropathic pain. 1
Dose Optimization First
The FDA label clearly states that pregabalin can be dosed up to 600mg/day for neuropathic pain conditions, and specifically notes that patients not experiencing sufficient pain relief at 300mg/day who tolerate the medication can be increased to 600mg/day 1. Your patient is currently on 450mg/day, leaving room for optimization before adding combination therapy.
If Dose Optimization Fails: Add-On Therapy
If pain remains poorly controlled after reaching 600mg/day pregabalin (or if side effects prevent further dose escalation), add a tricyclic antidepressant (nortriptyline or desipramine) as your first-line combination therapy. 2
Recommended Algorithm:
Step 1: Add a Secondary Amine TCA
- Start nortriptyline 10-25mg at bedtime
- Titrate slowly by 10-25mg weekly to 75-100mg/day
- Alternative: desipramine with same dosing
- These have fewer anticholinergic effects than tertiary amines
- Screen ECG if patient >40 years old; avoid if cardiac conduction abnormalities 2
Step 2: If TCA Contraindicated or Not Tolerated, Add an SSNRI
- Duloxetine 30mg daily for 1 week, then 60mg daily (reduces nausea with gradual titration)
- Alternative: venlafaxine
- These are particularly useful if comorbid depression/anxiety 2
Step 3: For Localized Facial Pain, Consider Topical Therapy
- Topical lidocaine 5% patch applied to painful area
- Can be used alone or combined with systemic therapy 2
Specific Considerations for Facial Neuropathic Pain
The type of facial pain matters:
If Trigeminal Neuralgia or variant:
- Carbamazepine remains first-line (not pregabalin), but oxcarbazepine has equal efficacy with fewer side effects 3
- Lamotrigine or baclofen are alternatives
- Consider lacosamide as emerging evidence shows superior pain reduction compared to pregabalin (NRS reduction from 7.7 to 2.5 vs 7.6 to 4.27, p<0.001) 4, 5
- Botulinum toxin has demonstrated efficacy for refractory cases 5
If Post-Stroke or Continuous Neuropathic Facial Pain:
Important Caveats
Do not combine pregabalin with gabapentin - the FDA label explicitly states "efficacy of add-on pregabalin in patients taking gabapentin has not been evaluated" and no dosing recommendations exist for this combination 1
Avoid doses above 600mg/day pregabalin - no additional benefit demonstrated and significantly worse tolerability 1
Allow adequate trial duration - TCAs require 6-8 weeks including 2 weeks at maximum tolerated dose to assess efficacy 2
Monitor for anticholinergic effects with TCAs - dry mouth, orthostatic hypotension, constipation, urinary retention; bedtime dosing and slow titration minimize these 2